国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
282例β-内酰胺类抗菌药的不良反应分析
Analysis for 282 Cases of Adverse Drug Reaction of β lactam Antibiotics
投稿时间:2011-03-09  修订日期:2011-05-15
DOI:
中文关键词:  β-内酰胺类抗菌药  药品不良反应  合理用药
英文关键词:β-lactam antibiotics  Adverse drug reaction  Rational drug use
基金项目:
作者单位
潘海燕 南京大学医学院附属鼓楼医院药剂科(南京 210008) 
凌春燕 南京大学医学院附属鼓楼医院药剂科(南京 210008) 
朱青 南京大学医学院附属鼓楼医院药剂科(南京 210008) 
摘要点击次数: 1428
全文下载次数: 1276
中文摘要:
      摘 要 目的:了解我院2009~2010年β-内酰胺类抗菌药不良反应发生情况, 分析其影响因素, 以促进临床合理用药。方法:收集我院2009~2010年上报告国家药品不良反应监测中心的282例β-内酰胺类抗菌药的药品不良反应(ADR)报告,分别从患者年龄、性别、给药途径、使用药物种类以及临床表现等方面进行统计分析。结果:ADR涉及β-内酰胺类抗菌药共33种, 以头孢曲松居首位, 其次为头孢呋辛和氨曲南; 以静脉途径给药引发的ADR最多;282例ADR中, 大于60 岁患者构成比最高(28.72%);临床表现以皮肤及其附件损害最常见。结论:β-内酰胺类抗菌药发生ADR 与年龄、给药途径等多种因素相关, 应规范β-内酰胺类抗菌药的临床应用,减少ADR的发生。
英文摘要:
      ABSTRACT Objective:To investigate the reality and affecting factors of adverse drug reaction(ADR ) induced by β-lactam antibiotics in our hospital during 2009-2010, in order to promote the rational use of drug in clinic. Method:We classified and analyzed 282 cases of ADR of β-lactam antibiotics which is reported to National center for ADR Monitoring during 2009-2010, according to the aspects of patients' age and gender, administration route, species of drugs and clinical manifestations. Result:The ADR were caused by a total of 33 species of β-lactam antibiotics agents, among which Ceftriaxone ranked the first and was followed by Cefuroxime and Aztreonam; The most causing route was intravenous administration; of which, those patients' aged above 60 years accounted for 28.72%;the damage of skin and its annex were the most common clinical manifestations.Conclusion:Multiple factors contributed to the ADR, for example age and administration route. And the clinical application of β-lactam antibiotics of should be regulated to avoid or reduce the occurrence of ADR.
查看全文  查看/发表评论  下载PDF阅读器
关闭